MCFT vs TSLA

MCFT exhibits strong operational health with a Piotroski F-Score of 7/9 and a healthy current ratio of 2.07, though an Altman Z-Score was not provided. While the company consistently delivers massive earnings surprises and outperforms sector profitability averages, the stock is trading at a significant premium to its Graham Number ($15.67) and Intrinsic Value ($6.58). This valuation gap, combined with bearish insider selling and a 0/100 technical trend, offsets the positive fundamental momentum. The outlook is neutral as the market prices in high growth expectations that exceed current deterministic value baselines.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.